滤泡性淋巴瘤中的自体造血干细胞移植 - Suppr

Suppr

超能文献

ASCT in follicular lymphoma.

作者信息

Brown Jennifer R, Freedman Arnold S

出版信息

Nat Rev Clin Oncol. 2009 Jul;6(7):380-2. doi: 10.1038/nrclinonc.2009.87.

DOI:10.1038/nrclinonc.2009.87

PMID:19561632

Abstract

摘要

相似文献

ASCT in follicular lymphoma.

Nat Rev Clin Oncol. 2009 Jul;6(7):380-2. doi: 10.1038/nrclinonc.2009.87.

Intensified therapy followed by autologous stem-cell transplantation (ASCT) versus conventional therapy as first-line treatment of follicular lymphoma: a meta-analysis.

Hematol Oncol. 2013 Mar;31(1):29-33. doi: 10.1002/hon.2015. Epub 2012 Apr 4.

No CD117 expression on B progenitors in the regenerating bone marrow.

Int J Hematol. 1997 Aug;66(2):245-7. doi: 10.1016/s0925-5710(97)00056-x.

Long-term clinical and molecular remissions in patients with follicular lymphoma following high-dose therapy and autologous stem cell transplantation.

Ann Oncol. 2013 Jun;24(6):1609-15. doi: 10.1093/annonc/mds657. Epub 2013 Feb 7.

Value of autologous stem cell transplantation with purged bone marrow as first-line therapy for follicular lymphoma with high tumor burden: a GOELAMS phase II study.

Bone Marrow Transplant. 2000 Nov;26(9):971-7. doi: 10.1038/sj.bmt.1702631.

An update on the role of high-dose therapy with autologous or allogeneic stem cell transplantation in mantle cell lymphoma.

Curr Opin Oncol. 2004 Mar;16(2):106-13. doi: 10.1097/00001622-200403000-00004.

Carboplatin instead of cisplatin in combination with dexamethasone, high-dose cytarabine with or without rituximab (DHAC+/-R) is an effective treatment with low toxicity in Hodgkin's and non-Hodgkin's lymphomas.

Ann Hematol. 2017 Jun;96(6):943-950. doi: 10.1007/s00277-017-2981-2. Epub 2017 Apr 3.

Durable event-free survival following autologous stem cell transplant for relapsed or refractory follicular lymphoma: positive impact of recent rituximab exposure and low-risk Follicular Lymphoma International Prognostic Index score.

Leuk Lymphoma. 2011 Nov;52(11):2124-9. doi: 10.3109/10428194.2011.594925. Epub 2011 Jul 8.

Autologous stem cell transplantation for follicular lymphoma: no benefit for early transplant?

Ann Hematol. 2001 Jul;80(7):398-405. doi: 10.1007/s002770100321.

A retrospective study of R-DHAP/Ox for early progressing follicular lymphoma.

Br J Haematol. 2018 Dec;183(5):828-831. doi: 10.1111/bjh.15057. Epub 2017 Dec 19.

引用本文的文献

High-dose therapy with autologous stem cell transplantation versus chemotherapy or immuno-chemotherapy for follicular lymphoma in adults.

Cochrane Database Syst Rev. 2012 Jan 18;1(1):CD007678. doi: 10.1002/14651858.CD007678.pub2.

本文引用的文献

High-dose therapy followed by autologous purged stem cell transplantation and doxorubicin-based chemotherapy in patients with advanced follicular lymphoma: a randomized multicenter study by the GOELAMS with final results after a median follow-up of 9 years.

Blood. 2009 Jan 29;113(5):995-1001. doi: 10.1182/blood-2008-05-160200. Epub 2008 Oct 27.

Impact of rituximab and/or high-dose therapy with autotransplant at time of relapse in patients with follicular lymphoma: a GELA study.

J Clin Oncol. 2008 Jul 20;26(21):3614-20. doi: 10.1200/JCO.2007.15.5358. Epub 2008 Jun 16.

Prospective, multicenter randomized GITMO/IIL trial comparing intensive (R-HDS) versus conventional (CHOP-R) chemoimmunotherapy in high-risk follicular lymphoma at diagnosis: the superior disease control of R-HDS does not translate into an overall survival advantage.

Blood. 2008 Apr 15;111(8):4004-13. doi: 10.1182/blood-2007-10-116749. Epub 2008 Jan 31.

Long-term survival after autologous bone marrow transplantation for follicular lymphoma in first remission.

Biol Blood Marrow Transplant. 2007 Sep;13(9):1057-65. doi: 10.1016/j.bbmt.2007.05.012. Epub 2007 Jul 16.

Myeloablative therapy with autologous bone marrow transplantation for follicular lymphoma at the time of second or subsequent remission: long-term follow-up.

J Clin Oncol. 2007 Jun 20;25(18):2554-9. doi: 10.1200/JCO.2006.09.8327. Epub 2007 May 21.

Standard chemotherapy with interferon compared with CHOP followed by high-dose therapy with autologous stem cell transplantation in untreated patients with advanced follicular lymphoma: the GELF-94 randomized study from the Groupe d'Etude des Lymphomes de l'Adulte (GELA).

Blood. 2006 Oct 15;108(8):2540-4. doi: 10.1182/blood-2006-03-013193. Epub 2006 Jul 11.

Increasing incidence of late second malignancies after conditioning with cyclophosphamide and total-body irradiation and autologous bone marrow transplantation for non-Hodgkin's lymphoma.

J Clin Oncol. 2005 Apr 1;23(10):2208-14. doi: 10.1200/JCO.2005.05.158. Epub 2005 Mar 7.

High-dose therapy followed by autologous purged stem-cell transplantation and doxorubicin-based chemotherapy in patients with advanced follicular lymphoma: a randomized multicenter study by GOELAMS.

Blood. 2005 May 15;105(10):3817-23. doi: 10.1182/blood-2004-10-3920. Epub 2005 Feb 1.

Myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission prolongs progression-free survival in follicular lymphoma: results of a prospective, randomized trial of the German Low-Grade Lymphoma Study Group.

Blood. 2004 Nov 1;104(9):2667-74. doi: 10.1182/blood-2004-03-0982. Epub 2004 Jul 6.

High-dose therapy improves progression-free survival and survival in relapsed follicular non-Hodgkin's lymphoma: results from the randomized European CUP trial.

J Clin Oncol. 2003 Nov 1;21(21):3918-27. doi: 10.1200/JCO.2003.10.023. Epub 2003 Sep 29.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验